1. Home
  2. Disease & Disorders
  3. Woodland Hills, CA
  4. Celiac Disease Foundation

Celiac Disease Foundation

Celiac Disease Foundation is ranked among disease & disorders organizations in Woodland Hills, CA, with an America's Best Score of 84 out of 100, based on its 2025 Form 990.

  • Woodland Hills, CA
  • Tax-exempt since 1995
  • EIN: 95-4310830
celiac.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
84OF 100 Ranked in Woodland Hills Disease & Disorders How this score is calculated

Organization summary

Celiac Disease Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G46Z). Contributions are tax-deductible.

21300 Victory Blvd Ste 300, Woodland Hills, CA 91367-7725

Among the 4 scored disease & disorders organizations in Woodland Hills, Celiac Disease Foundation holds 17.9 months of operating reserves (peer median 16.1 months), runs a typical yearly surplus of 28.7% (peers: surplus of 42.4%), and has grown spending 28.1% a year (peers: grown spending 15.3% a year).

In fiscal year 2025 it reported $5,315,881 in revenue and $4,579,989 in expenses, with contributions making up 48.3% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The Celiac Disease Foundation is the leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education.

Main program · fiscal year 2025

  • Researchthe Celiac Disease Foundation makes strategic investments in cutting-edge biomedical research and collaborates with researchers and clinicians to advance understanding of and treatments for celiac disease. In 2025, the foundation awarded nearly $500,000 in breakthrough grants focused on immune response to gluten and disease onset, funding projects at boston children's hospital, uc davis, C… Read more

    Researchthe Celiac Disease Foundation makes strategic investments in cutting-edge biomedical research and collaborates with researchers and clinicians to advance understanding of and treatments for celiac disease. In 2025, the foundation awarded nearly $500,000 in breakthrough grants focused on immune response to gluten and disease onset, funding projects at boston children's hospital, uc davis, Colorado children's hospital, children's national hospital, and beth israel deaconess medical center. The foundation sponsored major scientific gatherings including the tampere celiac disease symposium, the columbia university celiac disease on the horizon conference, the naspghan single topic symposium, and the Colorado screening symposium. In a landmark partnership, the north American society for the study of celiac disease (sscd) became the foundation's scientific advisory committee. The foundation's clinical trial recruitment platform, iqualifyceliac, surpassed 34,000 participating patients, while irecruitceliac supported 9 active trials across 9 new global partner organizations on 3 continents. The foundation also launched the first-ever celiac disease clinical trial site advisory council and the Celiac Disease Foundation impact fund, a venture philanthropy vehicle to fast-track breakthrough therapies and diagnostics from lab to patient.________________________________________advocacyin 2025, the Celiac Disease Foundation affirmed its role as the leading voice for celiac disease policy. The nih allocated $10 million for celiac disease research in fy2025, and celiac disease was included for the third consecutive year in the department of defense peer reviewed medical research program, with $1.58 million awarded. Advocates from 14 states attended the 2025 advocacy summit and hill day, meeting with 30 bipartisan congressional offices and sending more than 5,000 advocacy emails. Advocates from all 50 states submitted celiac disease awareness month proclamation requests, securing a record 27 states and Washington, d.c. CEO marilyn g. Geller represented celiac patients at the 48th session of the codex committee on food labelling in quebec city, securing amended labeling text, inclusion of celiac disease in mandatory prepackaged food labeling and precautionary allergen labeling guidelines, and a call for experts to inform setting a gluten threshold. The foundation also convened the global celiac advocacy alliance, uniting patient advocacy leaders from 12 organizations across 6 continents.________________________________________educationthe Celiac Disease Foundation provides innovative tools and programming to promote celiac disease education for patients, families, and healthcare professionals. Through celiac.org, the foundation offers a symptoms assessment tool, a nationwide practitioner directory, eat! Gluten-free meal plans, and the celiac disease management plan for school training program. Virtual programming - including culinary medicine webinars now available with live Spanish and portuguese translation - reached over 1,000 patients and 200 healthcare professionals in 2025. The foundation convened the college consensus summit to develop the first-ever national recommendations for supporting college students with celiac disease, and launched the Celiac Disease Foundation dietitian advisory council. Tools for healthcare professionals include the naspghan clinical guide for pediatric celiac disease, the celiac disease and psychological health training program, and accredited CME/ceu programs. The foundation reaches a global audience through celiac.org, social media channels with over 250,000 followers and 25 million views, and an e-newsletter with more than 100,000 subscribers.

    $3,189,546 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 70¢ went to programs, 17¢ to management and 13¢ to fundraising.

  • Programs $3,189,546
  • Management $790,648
  • Fundraising $599,795

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score84 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves17.9 mo; 4.7 mo in cash12.4 / 25
Financial balance (median margin)+28.7%18 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+28.1% / yr15 / 15
Track record31 years10 / 10
Debt load17.7% of assets8.5 / 10
Total83.9 → 84
Spending on programs
Not scored; America's Best needs 65%+
70%Meets

Compared with Woodland Hills peers

MeasureThis organizationPeer median
Operating reserves17.9 mo16.1 mo
Typical margin+28.7%+42.4%
Spending growth+28.1% / yr+15.3% / yr
Debt load17.7%7.6%

Peers: the 4 Woodland Hills disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$5,315,881Fiscal year 20252022: $3,118,62620222023: $4,203,44320232024: $4,294,35320242025: $5,315,8812025
Expenses$4,579,989Fiscal year 20252022: $2,177,59220222023: $2,975,23520232024: $4,336,07420242025: $4,579,9892025
Total assets$8,297,238Fiscal year 20252022: $4,468,40320222023: $5,959,85420232024: $7,559,14520242025: $8,297,2382025
Total liabilities$1,467,942Fiscal year 20252022: $595,64820222023: $633,79020232024: $2,000,12620242025: $1,467,9422025
Fiscal year ending December 2025
Revenue$5,315,881
Expenses$4,579,989
Net income$735,892
Net assets$6,829,296

Notable sources of revenue

Percent of total revenue
Contributions$2,568,848
Program services$2,389,372
Investment income$149,308
Other (net)$208,353

Assets / debt

Total assets$8,297,238
Total liabilities$1,467,942
Net assets$6,829,296

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$4,294,353
Expenses$4,336,074
Net income−$41,721
Net assets$5,559,019

Notable sources of revenue

Percent of total revenue
Contributions$2,407,287
Program services$1,662,305
Investment income$151,072
Other (net)$73,689

Assets / debt

Total assets$7,559,145
Total liabilities$2,000,126
Net assets$5,559,019

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$4,203,443
Expenses$2,975,235
Net income$1,228,208
Net assets$5,326,064

Notable sources of revenue

Percent of total revenue
Contributions$1,927,788
Program services$2,154,436
Investment income$125,118
Other (net)−$3,899

Assets / debt

Total assets$5,959,854
Total liabilities$633,790
Net assets$5,326,064

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$3,118,626
Expenses$2,177,592
Net income$941,034
Net assets$3,872,755

Notable sources of revenue

Percent of total revenue
Contributions$1,469,755
Program services$1,600,725
Investment income$27,932
Other (net)$20,214

Assets / debt

Total assets$4,468,403
Total liabilities$595,648
Net assets$3,872,755

Compensation

Officers and key employees$420,433
Share of expenses19.3%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?